Clinical Perinatal Software Market Size, Share & Trends Analysis Report By Product, By Deployment Model, By Application (Fetal Monitor Data Services, Workflow Management), By End Use, By Region,- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2025-2034

Clinical Perinatal Software Market Size and Trends

The clinical perinatal software market size was exhibited at USD 187.4 million in 2024 and is projected to hit around USD 499.49 million by 2034, growing at a CAGR of 10.3% during the forecast period 2025 to 2034.

Clinical Perinatal Software Market Size 2024 To 2034

Clinical Perinatal Software Market Key Takeaways:

  • Based on the product, the integrated segment held the largest revenue share of 80.0% in 2024.
  • Based on the deployment model, the on-premise segment held the largest revenue share, over 70.8%, in 2024.
  • Based on end use, the hospital/ clinics segment dominated the market with a revenue share of over 63.0% in 2024.
  • The maternity clinics segment is expected to exhibit the fastest CAGR over the forecast period.
  • Based on the application, the fetal monitor data services segment held the largest revenue share, over 53.3%, in 2024.
  • North America clinical perinatal software market dominated the market with a share of 49.7% in 2024.

U.S. clinical perinatal software market Size and Growth 2025 to 2034

The U.S. clinical perinatal software market size is evaluated at USD 70.3 billion in 2024 and is projected to be worth around USD 187.3 billion by 2034, growing at a CAGR of 9.31% from 2025 to 2034.

U.S. clinical perinatal software market Size 2024 To 2034

North America clinical perinatal software market dominated the market with a share of 49.7% in 2024. This strong position is driven by the region's advanced healthcare infrastructure, which supports integrating innovative technologies in maternal and neonatal care. Strategic partnerships and supportive regulatory frameworks reflect the commitment to improving health outcomes for mothers and infants. Furthermore, the significant healthcare spending and ongoing investments in research and development contribute to the widespread adoption of clinical perinatal software solutions, enhancing overall patient care and outcomes in the region.

Stacked Graph 0

U.S. Clinical Perinatal Software Market Trends

The U.S. clinical perinatal software market is experiencing significant growth driven by several key trends. The increasing integration of Artificial Intelligence (AI) and Machine Learning (ML) into perinatal software enhances predictive analytics, allowing healthcare providers to manage risks better and improve outcomes for mothers and infants. In addition, there is a rising demand for integrated software solutions that streamline workflows among healthcare professionals, making it easier to coordinate care.

The market is also shifting towards cloud-based deployment models offering real-time data access and greater flexibility. Furthermore, rising healthcare spending and government initiatives to improve maternal health awareness contribute to the widespread adoption of clinical perinatal software. With hospitals and maternity clinics increasingly implementing these solutions, the U.S. Clinical Perinatal Software Industry is well-positioned for continued growth in the coming years.

Europe Clinical Perinatal Software Market Trends

The Europe clinical perinatal software market is expected to grow significantly, driven by several key trends. A rapid rise in birth rates and an increase in post-date pregnancies is creating a greater demand for effective clinical perinatal software solutions. In addition, advancements in technology and the rising adoption of healthcare IT are enhancing the efficiency and functionality of these software systems. The market also benefits from government initiatives to improve maternal health awareness and care. Furthermore, the focus on integrated software solutions that streamline workflows among healthcare professionals is becoming increasingly important, as it allows for better coordination and improved patient outcomes across hospitals and maternity clinics. As a result, the Europe Clinical Perinatal Software industry is well-positioned for continued growth in the coming years.

Asia Pacific Clinical Perinatal Software Market Trends

The Asia Pacific clinical perinatal software market is expected to grow at the fastest CAGR of 11.5% during the forecast period. This growth is driven by increasing government initiatives aimed at improving maternal and fetal health and rising investments in healthcare infrastructure across the region. The demand for advanced healthcare solutions is being fueled by a growing awareness of maternal health issues and the need for effective monitoring during pregnancy.

In addition, expanding healthcare IT solutions supports the adoption of clinical perinatal software. Furthermore, efforts to boost birth rates in several countries, such as Japan, China, and India, within the region are set to promote the use of these software solutions, making the Asia Pacific market a key area for growth in clinical perinatal software over the coming years.

The Japan clinical perinatal software market is experiencing significant growth, driven by advancements in healthcare technology, increasing awareness of maternal and neonatal care, and the growing need for efficient patient management systems. Hospitals, maternity clinics, and other healthcare providers are adopting these solutions to improve patient care, streamline workflows, and enhance operational efficiency.

Supportive government initiatives and investments by key players in innovative products and cloud-based or on-premise solutions further contribute to this market expansion. The rising demand for high-quality prenatal and postnatal care makes perinatal software essential for managing complex patient data and ensuring better health outcomes. The clinical perinatal software industry is expected to continue evolving by integrating AI and machine learning technologies to provide more personalized and predictive care.

Report Scope of Clinical Perinatal Software Market

 Report Coverage  Details
Market Size in 2025 USD 206.7 Million
Market Size by 2034 USD 499.49 Million
Growth Rate From 2025 to 2034 CAGR of 10.3%
Base Year 2024
Forecast Period 2025-2034
Segments Covered Product, Deployment, Application, End use, Region
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Regional scope North America; Europe; Asia Pacific; Latin America; MEA
Key Companies Profiled PeriGen, Inc.; Koninklijke Philips N.V.; Trium Analysis Online GmbH; EDAN Instruments, Inc.; K2 Medical Systems Ltd.; Huntleigh Healthcare Limited.; Clinical Computer Systems, Inc.; General Electric Company

Clinical Perinatal Software Market By Product Insights

Based on the product, the integrated segment held the largest revenue share of 80.0% in 2024. This segment is also expected to grow fastest during the forecast period, driven by the increasing demand for seamless workflow integration among medical professionals. Factors such as technological advancements and a rise in product adoption further support this segment's growth.

The standalone segment is also expected to grow significantly over the forecast period. Standalone software is designed to focus on specific tasks, making it highly detailed and targeted. However, its growth may be limited due to drawbacks such as a lack of data integration and fewer options for add-ons, which could hinder its overall market expansion in the coming years.

Clinical Perinatal Software Market By Deployment Insights

Based on the deployment model, the on-premise segment held the largest revenue share, over 70.8%, in 2024. This dominance can be attributed to advantages such as data security, easy retrieval, and ease of access. Moreover, the customization option and reduced IT overhead cost are the factors propelling the segment's growth.

Cloud-based software is expected to exhibit the fastest CAGR over the forecast period. The growth can be attributed to real-time tracking and remote access to data. Moreover, advanced features such as high accessibility, increased flexibility, insignificant handling costs, and easy data backup are anticipated to boost the segment's growth in the forthcoming years.

Clinical Perinatal Software Market By End Use Insights

Based on end use, the hospital/ clinics segment dominated the market with a revenue share of over 63.0% in 2024. The large footfall and availability of advanced software within these facilities are the factors contributing to this segment's large revenue share. Most hospitals collaborate with various insurance companies for better and faster reimbursement procedures, thus increasing product adoption.

Pie Graph 0

The maternity clinics segment is expected to exhibit the fastest CAGR over the forecast period. An increasing number of maternity clinics in developed and developing countries is the primary growth driver for this segment. Rising disposable income and awareness are other significant factors driving the segment's growth in the forthcoming years.

Some of the prominent players in the clinical perinatal software market include:

Clinical Perinatal Software Market Recent Developments

  • In August 2023, PeriGen Inc. launched the LaborWatch platform, a breakthrough AI-powered tool for maternal-fetal assessments. Following successful implementation in a major U.S. health system, LaborWatch uses artificial intelligence to monitor labor progression and escalate persistent issues with automated SMS notifications. This innovative technology enhances healthcare providers' ability to track and address critical concerns in real-time, improving patient outcomes in labor and delivery.

  • In September 2023, GE HealthCare received a USD 44 million grant from the Bill & Melinda Gates Foundation to develop AI-assisted ultrasound tools to improve maternal and fetal health, especially in low- and middle-income countries. This funding allowed GE to create user-friendly applications that help healthcare professionals conduct effective ultrasound scans, even with limited training.

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the clinical perinatal software market

By Product

  • Integrated
  • Standalone

By Deployment Model

  • On-premise
  • Cloud-based

By Application

  • Fetal monitor data services
  • Workflow management
  • Patient documentation

By End Use

  • Hospital/Clinics
  • Maternity Clinics

By Regional

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

The clinical perinatal software market size was exhibited at USD 187.4 million in 2024 and is projected to hit around USD 499.49 million by 2034, growing at a CAGR of 10.3% during the forecast period 2025 to 2034.

North America dominated the clinical perinatal software market with a share of 49.71% in 2024. This is attributable to high disposable income, the presence of technologically advanced healthcare infrastructure, and rising awareness among patients.

Some key players operating in the clinical perinatal software market include Oracle (Cerner Corporation); PeriGen, Inc. (Halma plc); Koninklijke Philips NV; Trium Analysis Online; Edan Instruments Inc.; K2 Medical Systems etc., GE Healthcare; Huntleigh Healthcare Limited; Clinical Computer Systems, Inc.; AS Software LLC.

Key factors that are driving the market growth include steep rise in birth rate coupled with the growing number of post-date pregnancy. Moreover, rapid technological upgrades in perinatal software and increasing adoption of healthcare IT is further enhancing the adoption thereby promoting growth.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Market Definitions

1.3. Research Methodology

1.3.1. Information Procurement

1.3.2. Information or Data Analysis

1.3.3. Market Formulation & Data Visualization

1.3.4. Data Validation & Publishing

1.4. Research Scope and Assumptions

1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. Clinical Perinatal Software Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook

3.2. Market Size and Growth Prospects (USD Million)

3.3. Market Dynamics

3.3.1. Market Drivers Analysis

3.3.2. Market Restraints Analysis

3.4. Clinical Perinatal Software Analysis Tools

3.4.1. Porter’s Analysis

3.4.1.1. Bargaining power of the suppliers

3.4.1.2. Bargaining power of the buyers

3.4.1.3. Threats of substitution

3.4.1.4. Threats from new entrants

3.4.1.5. Competitive rivalry

3.4.2. PESTEL Analysis

3.4.2.1. Political landscape

3.4.2.2. Economic and Social landscape.

3.4.2.3. Technological landscape

3.4.2.4. Environmental landscape

3.4.2.5. Legal landscape

Chapter 4. Clinical Perinatal Software Market: Product Estimates & Trend Analysis

4.1. Product Market Share, 2025 & 2034

4.2. Product Segment Dashboard

4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)

4.4. Integrated

4.4.1. Integrated Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

4.5. Standalone

4.5.1. Standalone Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 5. Clinical Perinatal Software Market: Deployment Model Type Estimates & Trend Analysis

5.1. Deployment Model Market Share, 2025 & 2034

5.2. Deployment Model Segment Dashboard

5.3. Market Size & Forecasts and Trend Analysis, by Deployment Model, 2018 to 2030 (USD Million)

5.4. On-premise

5.4.1. On-premise Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

5.5. Cloud-based

5.5.1. Cloud-based Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 6. Clinical Perinatal Software Market: Application Estimates & Trend Analysis

6.1. Application Market Share, 2025 & 2034

6.2. Application Segment Dashboard

6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)

6.4. Fetal Monitor Data Services

6.4.1. Fetal Monitor Data Services Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

6.5. Workflow Management

6.5.1. Workflow Management Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

6.6. Patient Documentation

6.6.1. Patient Documentation Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 7. Clinical Perinatal Software Market: End Use Estimates & Trend Analysis

7.1. End Use Market Share, 2025 & 2034

7.2. End Use Segment Dashboard

7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)

7.4. Hospital/Clinics

7.4.1. Hospital/Clinics Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

7.5. Maternity Clinics

7.5.1. Maternity Clinics Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 8. Clinical Perinatal Software Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2025 & 2034

8.2. Regional Market Dashboard

8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:

8.4. North America

8.4.1. North America Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.4.2. U.S.

8.4.2.1. Key Country Dynamics

8.4.2.2. Regulatory Framework

8.4.2.3. Competitive Insights

8.4.2.4. U.S. Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.4.3. Canada

8.4.3.1. Key Country Dynamics

8.4.3.2. Regulatory Framework

8.4.3.3. Competitive Insights

8.4.3.4. Canada Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.4.4. Mexico

8.4.4.1. Key Country Dynamics

8.4.4.2. Regulatory Framework

8.4.4.3. Competitive Insights

8.4.4.4. Mexico Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.5. Europe

8.5.1. Europe Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.5.2. UK

8.5.2.1. Key Country Dynamics

8.5.2.2. Regulatory Framework

8.5.2.3. Competitive Insights

8.5.2.4. UK Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.5.3. Germany

8.5.3.1. Key Country Dynamics

8.5.3.2. Regulatory Framework

8.5.3.3. Competitive Insights

8.5.3.4. Germany Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.5.4. France

8.5.4.1. Key Country Dynamics

8.5.4.2. Regulatory Framework

8.5.4.3. Competitive Insights

8.5.4.4. France Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.5.5. Italy

8.5.5.1. Key Country Dynamics

8.5.5.2. Regulatory Framework

8.5.5.3. Competitive Insights

8.5.5.4. Italy Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.5.6. Spain

8.5.6.1. Key Country Dynamics

8.5.6.2. Regulatory Framework

8.5.6.3. Competitive Insights

8.5.6.4. Spain Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.5.7. Denmark

8.5.7.1. Key Country Dynamics

8.5.7.2. Regulatory Framework

8.5.7.3. Competitive Insights

8.5.7.4. Denmark Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.5.8. Sweden

8.5.8.1. Key Country Dynamics

8.5.8.2. Regulatory Framework

8.5.8.3. Competitive Insights

8.5.8.4. Sweden Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.5.9. Norway

8.5.9.1. Key Country Dynamics

8.5.9.2. Regulatory Framework

8.5.9.3. Competitive Insights

8.5.9.4. Norway Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.6. Asia Pacific

8.6.1. Asia Pacific Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.6.2. Japan

8.6.2.1. Key Country Dynamics

8.6.2.2. Regulatory Framework

8.6.2.3. Competitive Insights

8.6.2.4. Japan Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.6.3. China

8.6.3.1. Key Country Dynamics

8.6.3.2. Regulatory Framework

8.6.3.3. Competitive Insights

8.6.3.4. China Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.6.4. India

8.6.4.1. Key Country Dynamics

8.6.4.2. Regulatory Framework

8.6.4.3. Competitive Insights

8.6.4.4. India Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.6.5. Thailand

8.6.5.1. Key Country Dynamics

8.6.5.2. Regulatory Framework

8.6.5.3. Competitive Insights

8.6.5.4. Thailand Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.6.6. South Korea

8.6.6.1. Key Country Dynamics

8.6.6.2. Regulatory Framework

8.6.6.3. Competitive Insights

8.6.6.4. South Korea Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.6.7. Australia

8.6.7.1. Key Country Dynamics

8.6.7.2. Regulatory Framework

8.6.7.3. Competitive Insights

8.6.7.4. Australia Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.7. Latin America

8.7.1. Latin America Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.7.2. Brazil

8.7.2.1. Key Country Dynamics

8.7.2.2. Regulatory Framework

8.7.2.3. Competitive Insights

8.7.2.4. Brazil Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.7.3. Argentina

8.7.3.1. Key Country Dynamics

8.7.3.2. Regulatory Framework

8.7.3.3. Competitive Insights

8.7.3.4. Argentina Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.8. Middle East and Africa

8.8.1. Middle East and Africa Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.8.2. South Africa

8.8.2.1. Key Country Dynamics

8.8.2.2. Regulatory Framework

8.8.2.3. Competitive Insights

8.8.2.4. South Africa Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.8.3. Saudi Arabia

8.8.3.1. Key Country Dynamics

8.8.3.2. Regulatory Framework

8.8.3.3. Competitive Insights

8.8.3.4. Saudi Arabia Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.8.4. UAE

8.8.4.1. Key Country Dynamics

8.8.4.2. Regulatory Framework

8.8.4.3. Competitive Insights

8.8.4.4. UAE Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

8.8.5. Kuwait

8.8.5.1. Key Country Dynamics

8.8.5.2. Regulatory Framework

8.8.5.3. Competitive Insights

8.8.5.4. Kuwait Clinical Perinatal Software Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 9. Competitive Landscape

9.1. Participant Overview

9.2. Company Market Position Analysis

9.3. Company Categorization

9.4. Strategy Mapping

9.5. Company Profiles/Listing

9.5.1. PeriGen, Inc.

9.5.1.1. Participant’s Overview

9.5.1.2. Financial Performance

9.5.1.3. Product Benchmarking

9.5.1.4. Recent Developments/ Strategic Initiatives

9.5.2. Koninklijke Philips N.V.

9.5.2.1. Participant’s Overview

9.5.2.2. Financial Performance

9.5.2.3. Product Benchmarking

9.5.2.4. Recent Developments/ Strategic Initiatives

9.5.3. Trium Analysis Online GmbH

9.5.3.1. Participant’s Overview

9.5.3.2. Financial Performance

9.5.3.3. Product Benchmarking

9.5.3.4. Recent Developments/ Strategic Initiatives

9.5.4. EDAN Instruments, Inc.

9.5.4.1. Participant’s Overview

9.5.4.2. Financial Performance

9.5.4.3. Product Benchmarking

9.5.4.4. Recent Developments/ Strategic Initiatives

9.5.5. K2 Medical Systems Ltd.

9.5.5.1. Participant’s Overview

9.5.5.2. Financial Performance

9.5.5.3. Product Benchmarking

9.5.5.4. Recent Developments/ Strategic Initiatives

9.5.6. Huntleigh Healthcare Limited.

9.5.6.1. Participant’s Overview

9.5.6.2. Financial Performance

9.5.6.3. Product Benchmarking

9.5.6.4. Recent Developments/ Strategic Initiatives

9.5.7. Clinical Computer Systems, Inc.

9.5.7.1. Participant’s Overview

9.5.7.2. Financial Performance

9.5.7.3. Product Benchmarking

9.5.7.4. Recent Developments/ Strategic Initiatives

9.5.8. General Electric Company

9.5.8.1. Participant’s Overview

9.5.8.2. Financial Performance

9.5.8.3. Product Benchmarking

9.5.8.4. Recent Developments/ Strategic Initiatives

Proceed To Buy

USD 4500
USD 3900
USD 1900
USD 1200

Customization Offered

  • check-img Cross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert